Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MicroPort and Sorin Group Joint Venture Gets China's OK - Medical Product Outsourcing
Financial & Business, OEM News

MicroPort and Sorin Group Joint Venture Gets China’s OK

New partnership is slated to hit the ground running in June.

Chinese authorities have given their OK for a joint venture between MicroPort Scientific Corp. and Sorin Group. The new company received a registration certificate from Shanghai Administration for Industry and Commerce.

The Shanghai-based joint-venture company, named MicroPort Sorin CRM (Shanghai) Co. Ltd, is scheduled to begin operations in June.

The combined firm will go after the growing cardiovascular medical device market in China and will focus on developing cardiac rhythm management (CRM) devices (implantable pacemakers, defibrillators, cardiac resynchronization devices and related devices) in China.

MicroPort holds a 51 percent stake, while Sorin holds the remaining 49 percent.

In accordance with the agreement, MicroPort and Sorin will make initial capital contributions of, respectively, $10.2 million and $9.8 million in cash in the joint-venture. Under the agreement, the two companies will collaborate on the import, sale and service of Sorin’s CRM devices in China and, in accelerating the development of locally manufactured CRM products for the Chinese market.
MicroPort Scientific Corp. is a China-based medical device company. The firm maintains operations in the cardiovascular, orthopedics, electrophysiological, endovascular, neurovascular, surgical management, diabetes care, and endocrinal management markets.

Most recently, MicroPort made headlines for its acquisition of the large-joint (hips and knees) business of Wright Medical Technology Inc. The company’s new orthopedic arm is located in Arlington, Tenn.

The Milan, Italy-based Sorin Group makes medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With 3,750 employees worldwide, the company focuses on two major therapeutic areas: cardiac surgery (cardiopulmonary products for open heart surgery and heart valve repair or replacement products) and cardiac rhythm management (pacemakers, defibrillators, cardiac resynchronization devices).  – See more at: http://stagging_mpo.rodpub.com/issues/2014-03-01/view_columns/microport-and-sorin-partner-to-grab-share-of-chinas-crm-market/#sthash.g2ABfR5Z.dpuf

MicroPort Scientific Corp. is a China-based medical device company. The firm maintains operations in the cardiovascular, orthopedics, electrophysiological, endovascular, neurovascular, surgical management, diabetes care, and endocrinal management markets.

Most recently, MicroPort made headlines for its acquisition of the large-joint (hips and knees) business of Wright Medical Technology Inc. The company’s new orthopedic arm is located in Arlington, Tenn.

The Milan, Italy-based Sorin Group makes medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With 3,750 employees worldwide, the company focuses on two major therapeutic areas: cardiac surgery (cardiopulmonary products for open heart surgery and heart valve repair or replacement products) and cardiac rhythm management (pacemakers, defibrillators, cardiac resynchronization devices).

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters